Top 0.01% — Titan
Michael Houghton
Virology · Hepatology
Edmonton, Canada
105 H-Index
1,275 Total Impact
GLNobel Prize in Physiology or Medicine (2020)0
GLLasker Award (2000)0
GLCanada Gairdner International Award0
NHRobert Koch Prize0
Overview
Michael Houghton is a virology specialist with an H-index of 105 at the University of Alberta. Nobel Prize 2020 for discovery of Hepatitis C virus. Based in Edmonton, Canada.
For Patients
- Pioneered the Molecular cloning approach for HCV identification, a technique still used by doctors worldwide
- Currently at University of Alberta in Edmonton, Canada
Biography
Michael Houghton is a British-Canadian virologist who was awarded the Nobel Prize in Physiology or Medicine in 2020 for the discovery of the Hepatitis C virus in 1989. His work enabled blood screening tests that have prevented millions of HCV infections worldwide.
Affiliations & Institutions
Research Impact
3 Publications
0 Total Citations
Published In
ScienceProc Natl Acad Sci USA
Key Publications
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
Genetic organization and diversity of the hepatitis C virus
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
Areas of Expertise
Pioneering Techniques
Medical Specialties
Clinical Knowledge & Procedures
Legacy Timeline
The life and contributions of Michael Houghton
1989
Identified the Hepatitis C virus
Led team at Chiron Corporation that cloned and identified HCV, ending decades of 'non-A, non-B hepatitis' mystery
2000
Lasker Award
Received the Lasker-DeBakey Clinical Medical Research Award for HCV discovery
2010
Appointed to University of Alberta
Named Li Ka Shing Professor of Virology and Director of the Li Ka Shing Institute
2020
Nobel Prize in Physiology or Medicine
Shared the Nobel Prize with Harvey Alter and Charles Rice for the discovery of Hepatitis C virus
Media Archive